CAS: 2166558-11-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | JNJ-55308942 REF: 4Z-J-007001CAS: 2166558-11-6 | - - - | To inquire | Tue 10 Dec 24 |
 | JNJ-55308942 REF: 3D-RLD55811CAS: 2166558-11-6 | Min. 95% | To inquire | Tue 14 Jan 25 |
 | JNJ-55308942 REF: TM-T37806CAS: 2166558-11-6 | 100% | 76.00 €~2,016.00 € | Tue 21 Jan 25 |
Ref: 4Z-J-007001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
JNJ-55308942
CAS:2166558-11-6
JNJ-55308942 is a human Chinese nalbuphine analog that has been found to have anticancer properties. …
Formula:
C17H12F5N7O
Purity:
Min. 95%
Molecular weight:
425.3 g/mol
Ref: 3D-RLD55811
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
JNJ-55308942
CAS:2166558-11-6
JNJ-55308942: selective, brain-penetrant P2X7 antagonist; IC50s: 10nM (human), 15nM (rat); Kis: 7.1nM (h), 2.9nM (r).
Formula:
C17H12F5N7O
Purity:
100%
Color and Shape:
Liquid
Molecular weight:
425.32
Ref: TM-T37806
| 1mg | 76.00 € | ||
| 5mg | 166.00 € | ||
| 10mg | 259.00 € | ||
| 25mg | 499.00 € | ||
| 50mg | 720.00 € | ||
| 100mg | 1,003.00 € | ||
| 500mg | 2,016.00 € | ||
| 1mL*10mM (DMSO) | 178.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
